MedTech Innovator, the world’s largest accelerator for medical technology startups, has announced its 2025 Accelerator Cohort, comprising 65 standout companies chosen from nearly 1,500 global applicants. This cohort reflects the top four percent of early and mid-stage startups across diagnostics, devices, and digital health, each selected for their potential to transform healthcare. The program serves as a comprehensive platform for de-risking innovation and advancing these companies toward U.S. market access.

By joining the accelerator, participants gain access to MedTech Innovator’s unparalleled ecosystem of strategic manufacturers, investors, payers, providers, and mentors. The selected companies will receive expert guidance, non-dilutive funding opportunities totaling $800,000, and the chance to present at prestigious conferences such as The MedTech Conference and MedTech Strategist Innovation Summit. The program’s structure enables these innovators to refine their business strategies, improve product-market fit, and fast-track commercialization while joining a high-performing alumni network that has raised over $10 billion to date.

This year’s cohort underscores the accelerator’s mission to elevate solutions that address critical clinical needs globally. Through strong industry partnerships, including with Johnson & Johnson MedTech and the American Heart Association, MedTech Innovator continues to champion startups that are shaping the future of patient care. The 2025 program promises to be a launchpad for breakthrough technologies that will drive real-world impact across surgical care, cardiovascular health, neurology, regenerative medicine, and beyond.